14.40 (-%)
As of Nov 20, 2024
Source:
Prothena is a late-stage clinical biotechnology company with expertise in protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare peripheral amyloid diseases.
| Country | Ireland |
| Headquarters | dublin 2 |
| Phone Number | 011-353-1-236-2500 |
| Industry | manufacturing |
| CEO | Gene G. Kinney |
| Website | www.prothena.com |